With the recent development of short interfering RNA and short hairpin RNA expression libraries, RNA interference (RNAi) technology has been extensively employed to identify genes involved in diverse cellular processes, such as signal transduction, cell cycle, cancer biology and host -pathogen interactions. In the field of viral infection, this approach has already identified hundreds of new genes not previously known to be important for various virus lifecycles. In this brief review, we focus on recent studies performed using genome-wide RNAi-based screens in mammalian cells for the identification of essential host factors for viral infection and pathogenesis.
Introduction
Viruses are intracellular parasites that exploit host cell machineries in every step of their lifecycles. 1, 2 In recent years, it has become clear that human cells conserve the RNA interference (RNAi) machinery found across plant and animal kingdoms. 3 The RNA-dependent gene-silencing process was initially described for the nematode Caenorhabditis elegans wherein double-stranded RNAs (dsRNAs) can trigger the cleavage and subsequent degradation of sequence homologous mRNA transcripts. 4 Indeed, increasing amounts of experimental findings are consistent with the RNAi mechanism being employed by human cells to restrict viral infections. 5 -10 Accordingly, viruses have evolved RNAi suppressors, 11 -18 which may serve to change the small non-coding RNA profile in virus-infected host cells. 19 -21 The conservation of RNAi-machinery in human cells has allowed for the development of RNAi-based, genome-wide screening techniques to identify and investigate the cellular factors involved in viral replication and pathogenesis. Originally developed in C. elegans and Drosophila using long dsRNA, 22 -25 large-scale RNAi screens have been successfully applied using either synthetic short interfering RNAs (siRNAs) or vector-expressed short hairpin RNAs (shRNAs) for mammalian cells. 26 -31 Genome-scale RNAi screens in mammalian cells have been performed for studies in cancer biology and host -pathogen interactions. 32 -44 Here, we review in brief the extant experience of RNAi-based screens using siRNAs and shRNAs to study the cell factors used by various viruses for replication in host cells.
siRNA and shRNA methods for RNAi-based genome-wide screens Two methodological approaches have been applied commonly for RNAi-based genome screenings -large-scale transfections using a synthetic siRNA library or viral transduction of an shRNA library into cells (Figure 1 ). These two methods are typically performed using two different formats. The application of siRNA libraries is usually performed in a cell-based array (commonly in 96-or 384-well microtiter plates), in which individual genes are silenced in each well. On the other hand, the shRNA library is applied in a pooled format, where the entire library is introduced into cells and a subsequent selection and/or screening readout is employed in bulk. Both of these approaches have been successfully used to study different biological processes, and each has advantages and disadvantages.
In the arrayed format, the siRNAs are transfected into cells, and the detection of the assay is monitored by individual readouts from each well (e.g. colorimetric, fluorescence or luminescence plate reading). The advantage of this assay is that the plate format facilitates high throughput manipulations, and that the identity of the gene candidate is directly given by the position on the plate. Moreover, several parameters can be evaluated for each well or targeted gene. However, when a large number of genes are targeted in a genome-scale analysis, numerous plates must be screened in a 'labor-intensive' manner which would require the use of robotic machines. Also, because the siRNA-based screenings are transfection-based, this approach can be applied best to cells that are easily transfected, and thus the approach may not be useful for studies that require primary cells which are often difficult to transfect.
In a separate approach, retroviral vectors expressing shRNAs packaged into lentiviral particles are used to constitute an shRNA library that can be transduced into cells in a pooled format. 27, 28 These particles can be employed to stably transduce target cells, and the cells can be enriched by the selection of a co-transduced drug marker. shRNA-transduced cells can then be infected by virus, and the resulting outcome can be phenotypically characterized. For example, in a recent assay, cells that survived lytic infection by human immunodeficiency virus type 1 (HIV-1) represented those that had received an shRNA which had knocked down a cellular protein needed for intracellular HIV-1 replication. 34 Alternatively, depending on how the assay is set up, infected cells could be isolated using fluorescence-activated cell sorter (FACS) or other readouts. Thus, in an shRNA screening focused on kinases and phosphatases genes, Rato et al. 45 used FACS to eliminate HIV-infected cells and selected for cells which were resistant to HIV. In this way, they were able to implicate specific cellular kinases and phosphatases that act in the HIV-1 lifecycle. In the shRNA-library transduction approach, the shRNAs resident in the selected cells can then be amplified by polymerase chain reaction followed by sequencing or microarray hybridization for direct identification. An advantage of the shRNA-transduction approach using lentiviral particles instead of transfection is that transduction can introduce genetic material into a much larger range of dividing and nondividing cells. Hence, this method is amenable for studying primary cells that may otherwise be refractory to transfection. Pooled shRNA screenings are also more easily conducted by most laboratories because this type of screening can generally be successfully executed without the need for expensive robotic tools.
RNAi-based genome-wide screens applied to host-virus interactions studies
Genomewide screenings in mammalian cells have been used for HIV, 34, 39, 42, 43 influenza viruses, 32, 33, 38 West Nile virus 41 and hepatitis C virus, 35, 37 among others. We discuss in brief some of these screenings below.
HIV
In the literature, there are currently four studies of genomewide screenings for host cell factors that are important for HIV-1 gene expression and replication (Table 1) . 34, 39, 42, 43 Out of the four HIV screens, three were performed using siRNAs. 39, 42, 43 Two of these used siRNA transfection into HeLa cells engineered to express the viral receptor CD4 followed by infection with virus. 39, 43 Thus, Brass et al. 43 investigated early and late steps of the HIV lifecycle (from viral entry to virus budding and infectivity), and identified 273 genes out of a total of 20,000 mRNAs that were knocked down. By comparison, Zhou et al. 39 used a similar strategy and found 232 candidate genes. Surprisingly, between the two studies only 15 genes overlapped. A third study by Konig et al. 42 focused only on the early steps of the HIV lifecycle, from uncoating to protein synthesis. This system differed from the previous two screenings in its use of 293T cells instead of HeLa, and in the use of a virus pseudotyped with vesicular stomatitis virus G protein. Not surprisingly, of the 295 genes identified, very limited overlap was observed between this work, 42 and the two other studies. 39, 43 The lack of overlap between these three screenings illustrates that in different settings different genes may be limiting for HIV-1 replication. The issue then becomes how does one interpret meaningfully these divergent findings. 46, 47 Bushman et al. 48 attempted a meta-analysis to integrate the three siRNAs screens together with data obtained from other methods. The analyses showed that variations between replicates, between time points and between filtering thresholds all likely contributed to the differences observed between the siRNA screens. A take-home message appears to be that the various studies converge more at identifying relevant cellular pathways rather than at identifying the exact same genes within a commonly identified pathway. 46 A fourth HIV study was performed by Yeung et al. 34 using an shRNA library transduced into cells in a pooled format. The shRNA screening employed transduction instead of transfection; thus the investigators could use suspension Jurkat human T-cells which is a more physiological .............................................................................................................................................. target cell model for HIV-infection than the adherent HeLa and 293T cells used in the three siRNA screens. The shRNA approach also allows for stable durable knockdown of cellular mRNAs over an extended time period. Thus, indirect apparent effects on viral replication due to cytotoxicity from the knockdown of certain genes are less likely to emerge as false-positive candidates in the shRNA-than the siRNA-screening. In the approach performed by Yeung et al., cells were transduced with an shRNA library that targeted 54,509 human transcripts, and then the cells were selected over three weeks with puromycin for those that had stably taken up an shRNA. (Each shRNA in the library was marked with a puromycin-resistance gene.) At this stage, the analysis of puromycin-selected cells by Yeung et al. showed that only shRNA clones targeting 9357 genes out of the starting 54,509 were still represented in the surviving cells. This result suggested that only 18.2% of the cell's total transcripts can be tolerably knocked down without affecting Jurkat cell viability in tissue culture. A corollary of this finding is that the extended knockdown of 82% of cellular transcripts is cytotoxic to cells in tissue culture. The puromycin-resistant cells were then infected for an additional four weeks with HIV-1, and cells that survived lytic infection by the virus were analyzed for their shRNA content. The microarray hybridization results showed that shRNAs targeting 252 distinct transcripts were enriched between 2-and 22-fold in the survivor cells. These transcripts represent candidate cellular factors that contribute to HIV-1 replication in Jurkat cells. Of course, further detailed functional validations are needed before one can understand how each gene affects HIV-1 propagation in Jurkat cells. It should be noted that because their approach differed in both duration of selection and cell type which was employed, not unexpectedly, Yeung et al. observed only minimal overlap with genes identified in the other three siRNA studies. 39, 42, 43 Nevertheless, there was significant concordance in the pathways identified as important by Yeung et al. 34 and those identified earlier. 46 By combining the results of these four studies, 40 genes were found common to at least two of the four screens (Table 2) .
Influenza
To date, three independent genome-wide RNAi screens in mammalian cells have been published on identifying host factors important for influenza virus replication. Two of these studies were performed using the same human lung cell line A549, 32, 33 and the third one used osteosarcoma cells. 38 Whereas the study of Karlas et al. covered the entire viral replication cycle, from viral entry to budding, the other two studies were limited to the early and middle stages of the viral lifecycle, from virus entry to protein translation. By targeting more than 17,000 genes, they identified 120, 38 295 32 and 287 33 human genes involved in influenza virus replication. As in the case of HIV, only minimal overlap was observed in the lists of candidates from these three studies, with a maximum of 32 overlapping genes between the screens conducted by Konig et al. and Karlas et al. and a total of 49 genes found in at least two of the three screens ( Table 2) .
As was done for the HIV-1 analyses, Watanabe et al. 49 combined the results of these three influenza virus studies in a meta-analysis with data obtained from other methods, and finally arrived at a list of 128 human genes common to at least two genome-wide screens. Bioinformatics analysis of these genes revealed that they formed clusters of several proteins involved in similar host cellular functions important for the influenza virus lifecycle, such as endocytosis, nuclear transport and translation initiation.
Other viruses
Genome-wide siRNA-based screenings have been used in the study of two other viruses, West Nile virus (WNV) and hepatitis C virus (HCV). Krishnan et al. 41 recently identified 305 host factors that influence infection by WNV, with 283 factors facilitating and 22 antagonizing virus infection. Interestingly, the study also revealed that the silencing of 36% of the host factors used by WNV also reduced infection by dengue virus, a related flavivirus. Two studies concerning HCV were recently published (Table 1) . Tail et al. 35 reported 96 genes candidates for HCV virus replication using a subgenomic replicon system. However, the replicon system was not able to address the full HCV lifecycle. Using a different system recapitulating the complete lifecycle of the virus, Li et al. 37 identified 262 host factors important for HCV replication. Over 30 of the genes were previously implicated in the replication of HCV or WNV (a related flavivirus) using functional genomic studies. A comparison of Li et al. with the work of Tail et al. 35 performed with a HCV replicon system showed an overlap of 15 genes out of 96 identified (Table 2) . Interestingly, when compared with the host factors identified for HIV, the analysis revealed 10 common factors needed for the replication of both HIV and HCV. This is of particular interest considering that an estimated 25 -30% of HIV-infected individuals are chronically co-infected with HCV. 50 
Conclusion
Genome-wide RNAi-based screening represents a powerful new approach for the identification of host factors involved in the virus lifecycle. To date, at least several hundreds of potential candidate genes have been identified in the few screenings discussed here for the various viruses. Moreover, considering that there was only limited concordance between the different screenings, this suggests that viral infection in varying settings may be limited by different factors. Thus, the picture for 'required' cellular factors for virus replication in human cells may be quite complex. Accordingly, future screenings will likely identify several hundreds more candidates, each specific for divergent scenarios. An ultimate goal is for investigators to carefully validate the mechanism whereby each identified candidate assists/detracts viral infection.
By comparing the list of factors identified for different types of viruses, we appreciate only a few common factors (Table 2 ). This is not surprising considering the poor overlap observed between independent screens conducted for the same virus. However, if data-sets for each virus could be accrued that analyze different cell types and different settings of infection and if more studies could be extended to additional viruses, then the ever larger list of genes could reveal informative patterns to tell which are factors common to many viruses and which are factors specific to individual viruses (under defined conditions).
The study by Yeung et al. 34 for HIV-1 is the first genomewide screen for host factors involved in virus infection using shRNA vectors in a pooled format. This method seems promising because it broadens the amenable range of cells for functional analyses that could otherwise be limited only to cells that are easily transfectible by siRNAs. Thus, shRNA-based lentiviral transductions could potentially be performed in physiologically relevant primary target cells. Moreover, the transduction approach offers numerous versatilities such as the use of a shRNA library under inducible expression and the use of cell sorting after selection of transduced cells for phenotypical readouts.
By accelerating the discovery of new host factors important for the virus replication, genome-wide RNAi-based screens will undoubtedly reveal new therapeutic targets. The next few years promise to be exciting and productive.
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HIV
Influenza HCV   ADRBK1  MED28  AHCYL1  JUN  RPS16  ARCN1  AKT1  MED4  AIG1  KIAA0652  RUNX1  CEBPD  ANAPC2  MED6  ARCN1  KPNB1  SF3A1  COPA  ANKRD30A2  MED7  ATP6AP1  LRP1B  SF3B1  COPB1  CAV2  MID11P1  ATP6AP2  LY6G6C  SF3B14  CTSF  CCNT1  MRE11A  ATP6V0B  MAP2K3  SNRP70  DLK1  CD4  NFKB1  ATP6V0C  MDM2  TNK2  DLX6  CH5T1  NUP153  ATP6V0D1  NHP2L1  TRIM28  HAS1  CTDP1  NUP98  ATP6V1A  NUP98  WDR18  IDS  CXCR4  RAB11  ATP6V1B2  NXF1  ITGA7  DDX3X  RAB28  BZRAP1  OPRS1  NOP5/NOP58  DMXL1  RANBP2  CD81  PHF2  NUAK2  EPAS1  RELA  CLK1  PIP5K1C  PI4KA  HMCN2  RGPD8  COPA  PLK3  RABEPK  IBTK  RNF26  COPB2  PPP1R14D  TRIM62  IDH1  RPL3  COPG  PRPF8  JAK1  TCEB3  FKBP8  PTPRN  MAP4  TNPO3  IGSF1  PTS  MED14  TRIM55  IKBKE  RACGAP1  MED19  WNK1  IL17RA  RPS10 In bold are the genes detected in more than two screens of the same virus. In red are the genes common between two different viruses HIV, human immunodeficiency virus; HCV, hepatitis C virus 
